Blog

A new self-administered drug for the treatment of Multiple Sclerosis has been approved by the US Food and Drug Administration (FDA). In a clinical trial, it outperformed an existing oral drug, with respect to decreasing relapses and new areas of nerve damage seen on MRI....

As physicians, we understand the tremendous value of cognitive, physical, and social activity in optimizing and preserving our abilities as we age. At first glance, it is easy to see COVID as an obstacle. However, there are many ways we can emerge from this period sharper, stronger and more resilient.

There just might be magic bullets to aging well. Dr. Scott Kaiser talks about his 7 pillars of success for as we get older. Find out more

Nineteen of PNI’s doctors have been recognized as Super Doctors in the 2021 announcement of this prestigious industry standard award. Of note, Daniel F. Kelly, MD, Founder and Director of PNI, and expert neurosurgeon became a Hall of Fame Super Doctor. With his selection to...

Will & Cary Singleton Donate $40 Million to Pacific Neuroscience Institute’s Brain Health Center for Alzheimer’s Treatment & Research SANTA MONICA (July 7, 2020) –A $40 million donation from Will and Cary Singleton will support the Pacific Neuroscience Institute (PNI) Brain Health Center at Providence...

U.S. News & World Report highlights quality, specialty care Ten Providence Southern California hospitals and affiliated partners in Los Angeles and Orange counties earned recognition on July 28, 2020, from U.S. News & World Report. With approximately 415 acute care hospitals in California, the 10...

Find out about the new and ongoing neuroscience clinical trials at Pacific Neuroscience Institute, addressing difficult diseases such as brain tumors.

Exercise doesn’t just give you bigger muscles. It gives you a bigger brain. Scientists have measured brain volume in people who exercise and those who don’t. The exercisers had more.

Thought leaders and experts from MIT, Harvard, UC San Diego, and even Deepak Chopra himself recently collaborated together on a timely review article to highlight the rationale and urgent need to explore alternative and complementary therapies for combating COVID-19. This compelling narrative review concludes “certain...

A new paper co-authored by multiple sclerosis neurology specialist, Dr. Barbara Giesser, was published April 23, 2020, in Multiple Sclerosis Journal.